论文部分内容阅读
骨健灵是我院研制的一种含钙性复方散剂，用于小儿骨化醇缺乏性佝偻病防治，本实验采用模型动物治疗观察法，发现观察指标治疗组与对照组差别显著（P＜0.05），实验治疗效果可靠，对骨健灵进一步开展临床研究有指导意义。
Gujianling is a calcium-containing compound powder developed by our hospital for the prevention and treatment of ossifying alcohol deficiency rickets in children. In this experiment, animal model observation was used to observe that there was a significant difference between the observation group and the control group (P<0.05). ), The effect of experimental treatment is reliable, and it has guiding significance for the further clinical research of Gu Jianling.